'''Ultralente'' insulin is a long acting form of [[insulin]]. It has an onset of 4 to 6 hours, a peak of 14 to 24 hours, and a duration of 28 to 36 hours.<ref>Gomella LG, Haist SA. Chapter 22. Commonly Used Medications. In: Gomella LG, Haist SA, eds. Clinician's Pocket Reference: The Scut Monkey. 11th ed. New York: McGraw-Hill; 2007. http://www.accessmedicine.com/content.aspx?aID=2696124. Accessed February 4, 2012</ref>  This, along with [[Lente insulin|lente]] form of insulin, was discontinued in the US by  [[Eli Lilly and Company]] in 2005. One of the reasons for discontinuation was declining use due to physicians favoring [[NPH insulin]] and other basal insulin drugs.<ref>http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/ucm086084.pdf</ref>

== References ==
{{Reflist}}
{{Drug-stub}}
{{Oral hypoglycemics and insulin analogs}}
[[Category:Insulin therapies]]